lvv-hemorphin-7 has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bégu-Le Corroller, A; Feron, D; Fruitier-Arnaudin, I; Mancini, J; Maraninchi, M; Nogueira, JP; Piot, JM; Valéro, R; Vialettes, B | 1 |
| Cejka, J; Kunes, J; Velek, J; Zelezná, B; Zicha, J | 1 |
2 other study(ies) available for lvv-hemorphin-7 and Hypertension
| Article | Year |
|---|---|
Serum hemorphin-7 levels are decreased in obesity.
Topics: Adult; Blood Pressure; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Hypertension; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Peptide Fragments; Renin-Angiotensin System; Risk Factors | 2013 |
LVV-hemorphin-7 lowers blood pressure in spontaneously hypertensive rats: radiotelemetry study.
Topics: Animals; Blood Pressure; Heart Rate; Hemoglobins; Hypertension; Male; Peptide Fragments; Rats; Rats, Inbred WKY; Rats, Wistar; Telemetry | 2004 |